Follow
NADIA AMRANI
NADIA AMRANI
Associate Director, Excision BioTherapeutics
Verified email at excisionbio.com
Title
Cited by
Cited by
Year
A faux 3′-UTR promotes aberrant termination and triggers nonsense- mediated mRNA decay
N Amrani, R Ganesan, S Kervestin, DA Mangus, S Ghosh, A Jacobson
Nature 432 (7013), 112-118, 2004
6402004
Naturally occurring off-switches for CRISPR-Cas9
A Pawluk, N Amrani, Y Zhang, B Garcia, Y Hidalgo-Reyes, J Lee, A Edraki, ...
Cell 167 (7), 1829-1838. e9, 2016
4232016
Early nonsense: mRNA decay solves a translational problem
N Amrani, MS Sachs, A Jacobson
Nature reviews Molecular cell biology 7 (6), 415-425, 2006
3432006
A broad-spectrum inhibitor of CRISPR-Cas9
LB Harrington, KW Doxzen, E Ma, JJ Liu, GJ Knott, A Edraki, B Garcia, ...
Cell 170 (6), 1224-1233. e15, 2017
2742017
Pbp1p, a Factor Interacting withSaccharomyces cerevisiae Poly(A)-Binding Protein, Regulates Polyadenylation
DA Mangus, N Amrani, A Jacobson
Molecular and cellular biology 18 (12), 7383-7396, 1998
2461998
Translation factors promote the formation of two states of the closed-loop mRNP
N Amrani, S Ghosh, DA Mangus, A Jacobson
Nature 453 (7199), 1276-1280, 2008
2382008
Yeast Pab1 interacts with Rna15 and participates in the control of the poly (A) tail length in vitro
N Amrani, M Minet, M Le Gouar, F Lacroute, F Wyers
Molecular and cellular biology, 1997
1771997
NmeCas9 is an intrinsically high-fidelity genome-editing platform
N Amrani, XD Gao, P Liu, A Edraki, A Mir, R Ibraheim, A Gupta, KE Sasaki, ...
Genome Biology 19, 1-25, 2018
1302018
PCF11 Encodes a Third Protein Component of Yeast Cleavage and Polyadenylation Factor I
N Amrani, M Minet, F Wyers, ME Dufour, LP Aggerbeck, F Lacroute
Molecular and cellular biology 17 (3), 1102-1109, 1997
1201997
An engineered ScCas9 with broad PAM range and high specificity and activity
P Chatterjee, N Jakimo, J Lee, N Amrani, T Rodríguez, SRT Koseki, ...
Nature Biotechnology 38 (10), 1154-1158, 2020
1162020
All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo
R Ibraheim, CQ Song, A Mir, N Amrani, W Xue, EJ Sontheimer
Genome biology 19, 1-11, 2018
1082018
Aberrant termination triggers nonsense-mediated mRNA decay
N Amrani, S Dong, F He, R Ganesan, S Ghosh, S Kervestin, C Li, ...
Biochemical Society Transactions 34 (1), 39-42, 2006
1072006
Potent Cas9 inhibition in bacterial and human cells by AcrIIC4 and AcrIIC5 anti-CRISPR proteins
J Lee, A Mir, A Edraki, B Garcia, N Amrani, HE Lou, I Gainetdinov, ...
MBio 9 (6), 10.1128/mbio. 02321-18, 2018
912018
Structures of Neisseria meningitidis Cas9 complexes in catalytically poised and anti-CRISPR-inhibited states
W Sun, J Yang, Z Cheng, N Amrani, C Liu, K Wang, R Ibraheim, A Edraki, ...
Molecular cell 76 (6), 938-952. e5, 2019
832019
Toeprint analysis of the positioning of translation apparatus components at initiation and termination codons of fungal mRNAs
MS Sachs, Z Wang, A Gaba, P Fang, J Belk, R Ganesan, N Amrani, ...
Methods 26 (2), 105-114, 2002
802002
Genetic variability for haploid production in crosses between tetraploid and hexaploid wheats with maize
N Amrani, A Sarrafi, G Alibert
Plant Breeding 110 (2), 123-128, 1993
611993
Translational competence of ribosomes released from a premature termination codon is modulated by NMD factors
S Ghosh, R Ganesan, N Amrani, A Jacobson
Rna 16 (9), 1832-1847, 2010
562010
The use of fungal in vitro systems for studying translational regulation
C Wu, N Amrani, A Jacobson, MS Sachs
Methods in enzymology 429, 203-225, 2007
482007
Yeast Upf1 CH domain interacts with Rps26 of the 40S ribosomal subunit
EE Min, B Roy, N Amrani, F He, A Jacobson
Rna 19 (8), 1105-1115, 2013
462013
CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease
E Tsagkaraki, SM Nicoloro, T DeSouza, J Solivan-Rivera, A Desai, ...
Nature Communications 12 (1), 6931, 2021
442021
The system can't perform the operation now. Try again later.
Articles 1–20